Comerica Bank
BIO icon

Comerica Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Comerica Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.74M Sell
12,350
-6,747
-35% -$2.11M 0.01% 765
2025
Q3 		$5.35M Buy
19,097
+4,621
+32% +$1.26M 0.02% 653
2025
Q2 		$3.49M Sell
14,476
-1,178
-8% -$278K 0.01% 840
2025
Q1 		$3.81M Sell
15,654
-44,121
-74% -$13.3M 0.02% 794
2024
Q4 		$19.6M Buy
59,775
+4,609
+8% +$1.56M 0.08% 238
2024
Q3 		$18.5M Buy
55,166
+9,197
+20% +$2.92M 0.07% 262
2024
Q2 		$12.6M Buy
45,969
+8,915
+24% +$2.59M 0.05% 340
2024
Q1 		$12.8M Sell
37,054
-1,964
-5% -$646K 0.06% 344
2023
Q4 		$12.6M Buy
39,018
+8,180
+27% +$2.56M 0.06% 330
2023
Q3 		$11.1M Buy
+30,838
New +$11.9M 0.06% 333
2022
Q4 		$12.2M Buy
26,781
+2,141
+9% +$864K 0.09% 217
2022
Q3 		$9.31M Buy
24,640
+801
+3% +$399K 0.08% 256
2022
Q2 		$11.7M Buy
23,839
+3,661
+18% +$1.91M 0.1% 198
2022
Q1 		$11.3M Buy
20,178
+1,255
+7% +$757K 0.08% 239
2021
Q4 		$10.9M Sell
18,923
-2,165
-10% -$1.62M 0.08% 245
2021
Q3 		$15.9M Sell
21,088
-4,638
-18% -$3.47M 0.1% 191
2021
Q2 		$20M Buy
25,726
+3,914
+18% +$2.38M 0.12% 140
2021
Q1 		$14M Buy
21,812
+2,430
+13% +$1.44M 0.08% 229
2020
Q4 		$11.5M Buy
19,382
+6,960
+56% +$3.96M 0.07% 270
2020
Q3 		$7.23M Buy
12,422
+3,408
+38% +$1.73M 0.05% 412
2020
Q2 		$4.69M Sell
9,014
-9,575
-52% -$4.23M 0.04% 566
2020
Q1 		$8.05M Sell
18,589
-571
-3% -$210K 0.07% 273
2019
Q4 		$7.03M Buy
19,160
+654
+4% +$231K 0.05% 380
2019
Q3 		$6.3M Buy
18,506
+1,649
+10% +$538K 0.05% 413
2019
Q2 		$5.2M Sell
16,857
-1,489
-8% -$446K 0.04% 494
2019
Q1 		$5.64M Sell
18,346
-68
-0.4% -$18.4K 0.05% 454
2018
Q4 		$4.41M Buy
18,414
+455
+3% +$122K 0.04% 566
2018
Q3 		$4.96M Buy
17,959
+2,073
+13% +$643K 0.04% 510
2018
Q2 		$4.81M Sell
15,886
-489
-3% -$135K 0.03% 648
2018
Q1 		$4.29M Sell
16,375
-28
-0.2% -$7.13K 0.03% 715
2017
Q4 		$4.17M Buy
16,403
+221
+1% +$53.6K 0.03% 799
2017
Q3 		$3.54M Sell
16,182
-500
-3% -$113K 0.03% 836
2017
Q2 		$3.92M Buy
16,682
+134
+0.8% +$29.2K 0.03% 728
2017
Q1 		$3.6M Buy
16,548
+583
+4% +$112K 0.03% 797
2016
Q4 		$3.01M Buy
15,965
+1,061
+7% +$181K 0.02% 910
2016
Q3 		$2.4M Buy
14,904
+25
+0.2% +$3.79K 0.02% 951
2016
Q2 		$2.29M Buy
14,879
+444
+3% +$63.3K 0.02% 964
2016
Q1 		$2.02M Sell
14,435
-574
-4% -$75.4K 0.02% 1017
2015
Q4 		$1.96M Buy
15,009
+38
+0.3% +$5.27K 0.02% 980
2015
Q3 		$2.01M Sell
14,971
-14,833
-50% -$2.13M 0.02% 1003
2015
Q2 		$4.49M Buy
29,804
+14,807
+99% +$2.12M 0.02% 1011
2015
Q1 		$2.03M Sell
14,997
-15,185
-50% -$1.88M 0.02% 1072
2014
Q4 		$3.64M Buy
30,182
+14,695
+95% +$1.69M 0.02% 1121
2014
Q3 		$1.76M Buy
15,487
+400
+3% +$47.4K 0.02% 1145
2014
Q2 		$1.81M Sell
15,087
-1,405
-9% -$172K 0.02% 1154
2014
Q1 		$2.11M Buy
16,492
+247
+2% +$31.7K 0.02% 1109
2013
Q4 		$2.01M Sell
16,245
-1,318
-8% -$161K 0.02% 1115
2013
Q3 		$2.06M Buy
17,563
+453
+3% +$53.4K 0.01% 1117
2013
Q2 		$1.92M Buy
+17,110
New +$2.01M 0.02% 986

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Comerica Bank's BIO Position: Q4 2025 in Review

Comerica Bank reduced its Bio-Rad Laboratories Class A (BIO) stake by 35% in Q4 2025, selling an estimated $2.11M and leaving 12,350 shares worth $3.74M. The position accounts for 0.01% of the portfolio, ranked #765.

Comerica Bank first reported a position in BIO in Q2 2013 and has held it in 49 quarters since. The position peaked at $20M in Q2 2021. 397 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

  • Comerica Bank held 12,350 shares of Bio-Rad Laboratories Class A worth $3.74M as of Q4 2025.
  • Comerica Bank sold 6,747 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $2.11M.
  • Bio-Rad Laboratories Class A made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #765 holding.
  • Comerica Bank first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 49 quarters since.
  • Comerica Bank's Bio-Rad Laboratories Class A position peaked at $20M in Q2 2021.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.